Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 23201587)

1.

Dysregulated relationship of inflammation and oxidative stress in major depression.

Rawdin BJ, Mellon SH, Dhabhar FS, Epel ES, Puterman E, Su Y, Burke HM, Reus VI, Rosser R, Hamilton SP, Nelson JC, Wolkowitz OM.

Brain Behav Immun. 2013 Jul;31:143-52. doi: 10.1016/j.bbi.2012.11.011. Epub 2012 Nov 29.

2.

Increased oxidative stress in patients with depression and its relationship to treatment.

Chung CP, Schmidt D, Stein CM, Morrow JD, Salomon RM.

Psychiatry Res. 2013 Apr 30;206(2-3):213-6. doi: 10.1016/j.psychres.2012.10.018. Epub 2012 Dec 11.

3.

Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings.

Wolkowitz OM, Mellon SH, Epel ES, Lin J, Dhabhar FS, Su Y, Reus VI, Rosser R, Burke HM, Kupferman E, Compagnone M, Nelson JC, Blackburn EH.

PLoS One. 2011 Mar 23;6(3):e17837. doi: 10.1371/journal.pone.0017837.

4.

Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.

Bot M, Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Mann DL.

J Psychosom Res. 2011 Jul;71(1):13-7. doi: 10.1016/j.jpsychores.2010.11.006. Epub 2011 Jan 15.

5.

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.

Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S.

J Affect Disord. 2012 Dec 10;141(2-3):308-14. doi: 10.1016/j.jad.2012.03.033. Epub 2012 Apr 18.

PMID:
22516310
6.

Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder.

Behr GA, Moreira JC, Frey BN.

Oxid Med Cell Longev. 2012;2012:609421. doi: 10.1155/2012/609421. Epub 2012 May 27. Review.

7.

Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study.

Michalakeas CA, Parissis JT, Douzenis A, Nikolaou M, Varounis C, Andreadou I, Antonellos N, Markantonis-Kiroudis S, Paraskevaidis I, Ikonomidis I, Lykouras E, Kremastinos D.

J Card Fail. 2011 Sep;17(9):748-54. doi: 10.1016/j.cardfail.2011.05.004. Erratum in: J Card Fail. 2011 Oct;17(10):877. Lykouras, Evaggelos [corrected to Lykouras, Elefterios].

PMID:
21872145
8.

Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression.

Joaquim HP, Talib LL, Forlenza OV, Diniz BS, Gattaz WF.

J Psychiatr Res. 2012 Aug;46(8):1053-8. doi: 10.1016/j.jpsychires.2012.04.020. Epub 2012 May 22.

PMID:
22622071
9.

Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study.

Kotan VO, Sarandol E, Kirhan E, Ozkaya G, Kirli S.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul 1;35(5):1284-90. doi: 10.1016/j.pnpbp.2011.03.021. Epub 2011 Apr 15.

PMID:
21515329
10.

Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.

Dunjic-Kostic B, Ivkovic M, Radonjic NV, Petronijevic ND, Pantovic M, Damjanovic A, Poznanovic ST, Jovanovic A, Nikolic T, Jasovic-Gasic M.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:1-6. doi: 10.1016/j.pnpbp.2012.11.009. Epub 2012 Nov 28.

PMID:
23200828
11.

Connection between inflammatory markers, antidepressants and depression.

Crnković D, Buljan D, Karlović D, Krmek M.

Acta Clin Croat. 2012 Mar;51(1):25-33.

PMID:
22919999
12.

Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.

Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G, Cola C, Zanasi M, Troisi A, Siracusano A, Lauro R, Romeo F.

J Clin Psychiatry. 2006 Nov;67(11):1760-6.

PMID:
17196057
14.

Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.

Victor TA, Furey ML, Fromm SJ, Öhman A, Drevets WC.

Int J Neuropsychopharmacol. 2013 Nov;16(10):2195-208. doi: 10.1017/S146114571300062X. Epub 2013 Jul 1.

PMID:
23809145
15.

Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.

Amsterdam JD, Williams D, Michelson D, Adler LA, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF.

Neuropsychobiology. 2009;59(4):227-33. doi: 10.1159/000226611. Epub 2009 Jul 2.

PMID:
19571597
16.

Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.

Rethorst CD, Toups MS, Greer TL, Nakonezny PA, Carmody TJ, Grannemann BD, Huebinger RM, Barber RC, Trivedi MH.

Mol Psychiatry. 2013 Oct;18(10):1119-24. doi: 10.1038/mp.2012.125. Epub 2012 Aug 28.

17.

Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression.

Dhabhar FS, Burke HM, Epel ES, Mellon SH, Rosser R, Reus VI, Wolkowitz OM.

J Psychiatr Res. 2009 Jul;43(11):962-9. doi: 10.1016/j.jpsychires.2009.05.010. Epub 2009 Jun 23.

PMID:
19552919
18.

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.

Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ.

J Clin Psychiatry. 2010 Feb;71(2):109-20. doi: 10.4088/JCP.09m05347blu.

PMID:
20193645
19.

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.

Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L, Ruberto A, Tatarelli R, Nicoletti F, Girardi P, Shelton RC.

J Psychiatr Res. 2009 Jan;43(3):247-54. doi: 10.1016/j.jpsychires.2008.03.014. Epub 2008 Jun 3.

20.

Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study.

Brunoni AR, Kemp AH, Dantas EM, Goulart AC, Nunes MA, Boggio PS, Mill JG, Lotufo PA, Fregni F, Benseñor IM.

Int J Neuropsychopharmacol. 2013 Oct;16(9):1937-49. doi: 10.1017/S1461145713000497. Epub 2013 Jun 12.

PMID:
23759172
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk